Four notes:
1. The company saw full year sales of $14.9 million, a 41 percent jump compared to fiscal year 2021. Factors behind the increase include bolstered ZIP sales and a 200 percent increase in SiLO joint fusion system sales.
2. Margins grew to 52.5 percent in fiscal year 2022 due to higher margin sales to ASCs and increase pricing on some products.
3. Fourth quarter sales were $3.6 million, a 21.7 percent increase year-over-year.
4. Net loss in the fourth quarter was $840,000. For the fiscal year 2022, net loss was $1.5 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
